Years ago, when Peter French was in-charge, we toyed with the idea of using exosomes to deliver shrna. A European team has explored this concept for the treatment of Parkinson's. This non-viral delivery could have significant advantages over viral delivery where brain diseases are concerned. The early research is here.
Perhaps this is the kind of work (IP) that we could pick up relatively cheaply that would have good potential down the track?
Add to My Watchlist
What is My Watchlist?